Racial and ethnic disparities in disease-modifying therapy use among adults with multiple sclerosis: a real-world analysis of the All of Us Research Program
Introduction Racial and ethnic disparities in multiple sclerosis (MS) disease-modifying therapy (DMT) use are documented but incompletely characterized across the full treatment pathway. Methods We conducted a retrospective cohort study using the All of Us Research Program (2024 data release) among adults aged ≥18 year...